Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

2011 Scrip Asia 100 - CMIC shows first-mover advantage in Japan's CRO market

This article was originally published in Scrip

Executive Summary

Smart service providers align their business models with the evolving regulatory environment and the changing needs of their pharmaceutical customers. For CMIC, one of Japan's earliest CROs, and now its biggest, much future growth will come from meeting sponsors' demand for clinical data from emerging Asia, Masao Wakai tells Ian Haydock. This article is part of the 2011 Scrip Asia 100.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC013462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel